XETRA · MED.DE
Mediclin AG
€5.35+€0.10 (+1.9%)
Mediclin AG’s quoted price sits in the upper half of its reported 52-week range, 7.76% below the high.
Loading market information…
XETRA · LIK.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
LIMES Schlosskliniken AG’s quoted price sits in the upper half of its reported 52-week range, 11.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
LIMES Schlosskliniken AG’s next earnings report is currently expected on May 17, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow LIMES Schlosskliniken AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
LIMES Schlosskliniken AG oversees private healthcare facilities specializing in psychiatric, psychotherapeutic, and psychosomatic treatments. The organization primarily concentrates on addressing conditions arising from stress, alongside a variety of psychological and emotional disorders such as depression, severe burnout, mood disorders, and trauma. Headquartered in Cologne, Germany, LIMES Schlosskliniken AG operates as a subsidiary of GMF Capital GmbH.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€5.35+€0.10 (+1.9%)
Mediclin AG’s quoted price sits in the upper half of its reported 52-week range, 7.76% below the high.
SEK 2.03+SEK 0.08 (+3.89%)
H100 Group AB: Technology · Software - Application.
€28.40+€0.20 (+0.71%)
MPH Health Care AG’s quoted price sits in the upper half of its reported 52-week range, 4.38% below the high.
€2.14€0.00 (0.0%)
Heidelberg Pharma AG’s quoted price sits in the lower half of its reported 52-week range, 35.93% below the high.
£5.30£0.00 (0.0%)
4basebio PLC’s quoted price sits in the lower half of its reported 52-week range, 35.37% below the high.
€11.00€0.00 (0.0%)
Apontis Pharma AG’s quoted price sits in the lower half of its reported 52-week range, 10.93% below the high.
€10.50€0.00 (0.0%)
DocCheck AG’s quoted price sits in the lower half of its reported 52-week range, 33.96% below the high.
€2.79€0.00 (0.0%)
FamiCord AG’s quoted price sits in the lower half of its reported 52-week range, 60.98% below the high.
